Enanta Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
5.55
0.28
(5.31%)
Volume:
106,054
52 week range:
4.09 - 17.24
Market Cap:
118.396M
Company Description:
Enanta Pharmaceuticals, Inc. discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus.